Description
HU-211, 10MG (Dexanabinol)
The endocannabinoids present a rich system of central cannabinoid (CB1), peripheral cannabinoid (CB2), and non-CB receptor-mediated pharmacology that has stimulated research in many fields including memory, weight loss and appetite, neurodegeneration, tumor surveillance, analgesia, and inflammation.1,2 HU-211 is a synthetic terpene-based cannabinoid devoid of central cannabinoid (CB1) and peripheral cannabinoid (CB2) agonist activity, thus lacking the psychomotor responses characteristic of Δ9-THC. HU-211 does exhibit the neuroprotective, antioxidant properties of other related compounds like cannabidiol.3 HU-211 also has anti-inflammatory properties derived through inhibition of NF-κB and the
resulting decreases in cytokines such as TNFα and interleukin-6.
WARNING This product is not for human or veterinary use.
Technical Information- DMF: 30 mg/ml
- DMF:PBS (pH 7.2) (1:2): .25 mg/ml
- DMSO: 30 mg/ml
- Ethanol: 30 mg/ml